The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Cognitive Function, Fatigue, and Menopausal Symptoms in Women Receiving Adjuvant Chemotherapy for Breast Cancer
Abstract
Purpose: There is evidence that cognitive dysfunction, fatigue, and menopausal symptoms may occur in women receiving adjuvant chemotherapy for breast cancer. Here, we determine their incidence and severity, and interrelationships between them and quality of life. Patients and Methods: In this study, 110 women receiving adjuvant chemotherapy each nominated a female relative, friend, or neighbor (matched by age) as a control; 100 eligible matched pairs were evaluated. Patients and controls completed the following assessments: the High-Sensitivity Cognitive Screen, and the Functional Assessment of Cancer Therapy–General (FACT-G) quality of life scale with subscales for fatigue (FACT-F) and endocrine symptoms (FACT-ES). They also performed tests of attention and reaction time. Results: Patients and controls were well matched for age and level of education. There was a higher incidence of moderate or severe cognitive impairment in the patient group (16% v 4%; P = .008). Patients experienced much more fatigue than controls (median FACT-F scores, 31 v 46; P < .0001) and more menopausal symptoms (median FACT-ES scores, 58 v 64; P < .0001). Self-reported quality of life of the patients was poorer than for controls, especially in physical and functional domains (median FACT-G scores, 77 v 93; P < .0001). There was strong correlation between fatigue, menopausal symptoms, and quality of life (P < .0001 for each pair), but none were significantly associated with the presence of cognitive dysfunction. Conclusion: Adjuvant chemotherapy causes cognitive dysfunction, fatigue, and menopausal symptoms in women with breast cancer. Priority should be given to the study of strategies that might reduce these toxic effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
Interpreting the significance of changes in health-related quality-of-life scores.
Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.139 · Cited by 2,961
Focan, C., Steinberg, S. M., Blichert-Toft, M., Forbes, J., Collins, R. D., Anderson, S., Margreiter, R., Harwood, C. S., Andersen, K., Beighton, G., et al. (1998) · PubMed · Cited by 2,146
Polychemotherapy for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(98)03301-7 · Cited by 2,042
Yellen, S. B., Cella, D. F., Webster, K., Blendowski, C., & Kaplan, E. (1997) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(96)00274-6 · Cited by 1,964
Cytokine-Associated Emotional and Cognitive Disturbances in Humans
Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., Morag, A., & Pollmächer, T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.445 · Cited by 1,365
Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life.
Bower, J. E., Ganz, P. A., Desmond, K. A., Rowland, J. H., Meyerowitz, B. E., & Belin, T. R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.743 · Cited by 1,134
On the receiving end—patient perception of the side-effects of cancer chemotherapy
Coates, A., Abraham, S., Kaye, S. B., Sowerbutts, T., Frewin, C., Fox, R. M., & Tattersall, M. H. N. (1983) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(83)90418-2 · Cited by 997
Estrogen Therapy in Postmenopausal Women: Effects on Cognitive Function and Dementia
Yaffe, K., Sawaya, G., Lieberburg, I., & Grady, D. (1998) · JAMA · doi:10.1001/jama.279.9.688 · Cited by 941
van Dam, F. S. A. M., Boogerd, W., Schagen, S. B., Muller, M. J., Droogleever Fortuyn, M. E., Wall, E. V. D., & Rodenhuis, S. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.3.210 · Cited by 763
Ahles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., Whedon, M. B., Bivens, S., Mitchell, T., Greenberg, E. R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.485 · Cited by 736
Hormone Replacement Therapy and Cognition: Systematic Review and Meta-analysis
LeBlanc, E. S., Janowsky, J., Chan, B. K. S., & Nelson, H. D. (2001) · JAMA · doi:10.1001/jama.285.11.1489 · Cited by 659
Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma
Schagen, S. B., van Dam, F. S. A. M., Muller, M. J., Boogerd, W., Lindeboom, J., & Bruning, P. F. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990201)85:3<640::aid-cncr14>3.0.co;2-g · Cited by 620
Levine, M. N., Bramwell, V. H., Pritchard, K. I., Norris, B. D., Shepherd, L. E., Abu-Zahra, H., Findlay, B., Warr, D., Bowman, D., Myles, J., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2651 · Cited by 617
Self-citationRisk of Menopause During the First Year After Breast Cancer Diagnosis
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M., & Hood, N. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2365 · Cited by 606
Cognitive Function in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Brezden, C. B., Phillips, K.-A., Abdolell, M., Bunston, T., & Tannock, I. F. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.14.2695 · Cited by 557
Self-citationStone, P., Richardson, A., Ream, E., Smith, A. G., Kerr, D. J., & Kearney, N. (2000) · Annals of Oncology · doi:10.1023/a:1008318932641 · Cited by 438
The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast Cancer
Levine, M. N., Gent, M., Hirsh, J., Arnold, A., Goodyear, M. D., Hryniuk, W., & De Pauw, S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198802183180703 · Cited by 412
On the receiving end V: Patient perceptions of the side effects of cancer chemotherapy in 1993
Griffin, A. M., Butow, P. N., Coates, A. S., Childs, A. M., Ellis, P. M., Dunn, S. M., & Tattersall, M. H. N. (1996) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a010548 · Cited by 388
Factors influencing quality of life in cancer patients: anemia and fatigue.
Cella, D. F. (1998) · PubMed · Cited by 386
Fallowfield, L. J., Leaity, S. K., Howell, A., Benson, S., & Cella, D. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006263818115 · Cited by 354
Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer
Wieneke, M. H., & Dienst, E. R. (1995) · Psycho-Oncology · doi:10.1002/pon.2960040108 · Cited by 317
Managing Menopausal Symptoms in Breast Cancer Survivors: Results of a Randomized Controlled Trial
Ganz, P. A. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.13.1054 · Cited by 312
Lindley, C., Vasa, S., Sawyer, W. T., & Winer, E. P. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1380 · Cited by 296
Sherwin, B. B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3771-3 · Cited by 247
Sherwin, B. B. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.7.2545 · Cited by 198
Screening for Dementia and Investigating Its Causes
Siu, A. L. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-2-122 · Cited by 175
The impact of hemoglobin levels on fatigue and quality of life in cancer patients
Holzner, B., Kemmler, G., Greil, R., Kopp, M., Zeimet, A., Raderer, M., Hejna, M., Zöchbauer, S., Krajnik, G., Huber, H., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf122 · Cited by 173
Physical and psychologic distress associated with adjuvant chemotherapy in women with breast cancer.
Knobf, M. T. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.5.678 · Cited by 163
Fatigue in Patients With Breast Cancer Receiving Adjuvant Chemotherapy: A Review of the Literature
de Jong, N., Courtens, A. M., Abu-Saad, H. H., & Schouten, H. C. (2002) · Cancer Nursing · doi:10.1097/00002820-200208000-00004 · Cited by 161
A comparison of patient-reported side effects among three chemotherapy regimens for breast cancer.
Greene, D., Nail, L. M., Fieler, V. K., Dudgeon, D. J., & Jones, L. S. (1994) · PubMed · Cited by 117
Menopausal symptoms in breast cancer survivors.
Carpenter, J. S., & Andrykowski, M. A. (1999) · PubMed · Cited by 111
Symptoms and rehabilitation needs of patients with early stage breast cancer during primary therapy
Knobf, M. T. (1990) · Cancer · doi:10.1002/1097-0142(19900915)66:14+<1392::aid-cncr2820661415>3.0.co;2-t · Cited by 49
Natural menopause and ovarian toxicity associated with breast cancer therapy.
Knobf, M. T. (1998) · PubMed · Cited by 45
The Development and Initial Validation of a Sensitive Bedside Cognitive Screening Test
Faust, D., & Fogel, B. S. (1989) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198901000-00004 · Cited by 41
Benefits of Epoetin Alfa in Anemic Breast Cancer Patients Receiving Chemotherapy
Demetri, G. D., Gabrilove, J. L., Blasi, M. V., Hill, R. J., & Glaspy, J. A. (2002) · Clinical Breast Cancer · doi:10.3816/cbc.2002.n.011 · Cited by 38
Smith, S. S., & Sullivan, K. A. (2003) · International Journal of Behavioral Medicine · doi:10.1207/s15327558ijbm1002_05 · Cited by 29
Effects of tiapride on electroencephalograms and cognitive functions in the elderly
Patat, A. A., Albérini, H., Bonhomme, D., Soubrane, C., Allain, H., & Gandon, J. M. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199907000-00001 · Cited by 10
TRANSFER OF INFORMATION FROM TOUCH TO VISION IN BRAIN-INJURED AND EMOTIONALLY DISTURBED CHILDREN
Conners, C. K., & BARTA, F. (1967) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-196708000-00005 · Cited by 7
Management of Menopausal Symptoms in Breast Cancer Patients
Loprinzi, C. L., & Peethambaram, P. P. (1995) · Annals of Medicine · doi:10.3109/07853899509019251 · Cited by 6
Cited by
Cancer treatment and survivorship statistics, 2012
Siegel, R., DeSantis, C., Virgo, K., Stein, K., Mariotto, A., Smith, T., Cooper, D., Gansler, T., Lerro, C., Fedewa, S., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21149 · Cited by 2,928
Wefel, J. S., Vardy, J., Ahles, T., & Schagen, S. B. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70294-1 · Cited by 998
Candidate mechanisms for chemotherapy-induced cognitive changes
Ahles, T. A., & Saykin, A. J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2073 · Cited by 916
Cancer‐related fatigue: Evolving concepts in evaluation and treatment
Stasi, R., Abriani, L., Beccaglia, P., Terzoli, E., & Amadori, S. (2003) · Cancer · doi:10.1002/cncr.11742 · Cited by 712
Wefel, J. S., Lenzi, R., Theriault, R. L., Davis, R. N., & Meyers, C. A. (2004) · Cancer · doi:10.1002/cncr.20272 · Cited by 679
Metadata
- Authors
- Tchen, N., Juffs, H. G., Downie, F. P., Yi, Q.-L., Hu, H., Chemerynsky, I., Clemons, M., Crump, M., Goss, P. E., Warr, D., Tweedale, M. E., & Tannock, I. F.
- Venue
- Journal of Clinical Oncology
- Published
- 2003-11-15
- Volume
- 21
- Issue
- 22
- Pages
- 4175-4183
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2143418376
- Cited by
- 380
- References
- 42
- FWCI
- 16.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.